REACTOGENICITY OF HETEROLOGOUS MRNA-BASED COVID-19 VACCINE BOOSTER IN YOUNG ADULTS IN INDONESIA- A SHORT COMMUNICATION.

BACKGROUND: Heterologous priming with the inactivated SARS-CoV-2 vaccine (CoronaVac) and boosting with mRNA-based COVID-19 vaccine (Moderna or Pfizer) is currently recommended in Indonesia. The reactogenicity data of these heterologous vaccine regimens are not entirely available, particularly in you...

Descripción completa

Detalles Bibliográficos
Autores principales: Neneng, SURYADINATA, Mario, CHRISTOPHER Paulus, Michelle, IMANUELLY, Sari, WIJAYA Ratna, Cucunawangsih, CUCUNAWANGSIH, Hardjo, LUGITO Nata Pratama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: African Traditional Herbal Medicine Supporters Initiative (ATHMSI) 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158954/
https://www.ncbi.nlm.nih.gov/pubmed/37151753
http://dx.doi.org/10.21010/Ajidv17i2.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158954/
https://www.ncbi.nlm.nih.gov/pubmed/37151753
http://dx.doi.org/10.21010/Ajidv17i2.2

Ejemplares similares